Lisa is Portfolio Manager for Pivotal Life Sciences and Director at Group CEO Office, Nan Fung Group. Prior to joining Pivotal Life Sciences, Lisa was a senior research analyst at NF Trinity, Nan Fung Group’s financial investment arm, where she was responsible for the fund’s investments in the global healthcare sector. Prior to NF Trinity, Lisa was a senior analyst at Agamemnon Capital, a global event–driven hedge fund, where she focused on the healthcare sector, and she was also an Assistant Vice President at State Administration of Foreign Exchange (SAFE), the Chinese sovereign wealth fund, managing its global healthcare holdings. She started her career in private equity with Morgan Stanley. Lisa has served as Board Observer at Navitor Pharmaceuticals and SomaLogic (acquired by Standard BioTools). Lisa earned her MBA from The Wharton School at University of Pennsylvania, and her Bachelor of Science and Bachelor of Arts degrees from University of California, Berkeley.
